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Diffusion-weighted whole-body imaging
with background body signal suppression
(DWIBS): features and potential applications
in oncology
Abstract Diffusion-weighted
magnetic resonance imaging (DWI)
provides functional information and
can be used for the detection and
characterization of pathologic pro-
cesses, including malignant tumors.
The recently introduced concept of
“diffusion-weighted whole-body
imaging with background body signal
suppression” (DWIBS) now allows
acquisition of volumetric diffusion-
weighted images of the entire body.
This new concept has unique features
different from conventional DWI and
may play an important role in whole-
body oncological imaging. This
review describes and illustrates the
basics of DWI, the features of
DWIBS, and its potential applications
in oncology.
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Introduction
Cancer is the second leading cause of death in developed
countries, is among the three leading causes of death for
adults in developing countries, and is responsible for
12.5% of all deaths worldwide [1]. Once a malignant tumor
is detected, determination of disease extent (staging) is
important for appropriate treatment planning and determin-
ingprognosis.Imagingplaysapivotalroleincancerstaging.
Furthermore, imaging is of great importance in monitoring
response to therapy and inthe detectionof tumor recurrence.
Diffusion-weighted magnetic resonance imaging (DWI)
provides functional information and can be used for the
detection and characterization of pathologic processes,
including malignant tumors; it may therefore be of value in
staging and follow-up imaging of malignant tumors. DWI
using single-shot echo-planar imaging (EPI) is a well-
established method to examine the brain. Extracranial
DWI, however, did not become a clinical standard because
the use of EPI was complicated by magnetic susceptibility
artifacts and severe image distortion in the body [2–6].
Recently introduced parallel imaging techniques, such as
sensitivity encoding (SENSE) [7, 8], and the development
of stronger gradients and multichannel coils have largely
overcome this problem; DWI of adequate quality can now
be performed in the body, at high b-value [9, 10]. Despite
the above-mentioned breakthroughs in DWI, breathhold or
respiratory triggered scanning was still considered neces-
sary since it was widely accepted that respiratory motion
was an impediment for DWI of (moving) visceral organs
[11–15].
Then, in 2004, Takahara et al. [16] reported a unique
concept of whole-body DWI, called “diffusion-weighted
whole-body imaging with background body signal sup-
pression” (DWIBS). This technique intentionally uses free
breathing scanning rather than breathholding or respiratory
triggering to visualize (moving) visceral organs and their
lesions. In a later published article, Ballon et al. [17] also
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Kurume, Japanreported whole-body DWI during free breathing. The study
by Ballon et al. [17] aimed to visualize metastatic lesions in
static tissue (bone marrow); this was in agreement with
accepted theory at that time. However, they additionally
found that visceral organs, such as the spleen and kidneys,
were also visualized [17]. The feasibility of the free
breathing approach could initially not be explained, but
was clarified later; it can be understood with knowledge of
the relationship between the motion probing gradients
(MPGs) and the type (coherence) of motion, as will be
described in a later section. This concept offers a wide
range of potential applications in whole-body oncological
imaging.
The first purpose of this review is to acquaint the reader
with the features of DWIBS. Second, although evidence
regarding its effectiveness is still limited, the potential
applications of DWIBS in oncology will be described and
illustrated. Finally, drawbacks, limitations, and future
considerations of DWIBS will be discussed.
Basics of DWI
As introduced by Stejskal and Tanner [18], the most
common approach to render magnetic resonance imaging
(MRI) sensitive to diffusion is to place two strong
symmetrical gradient lobes (so-called MPGs) on either
side of the 180° refocusing pulse in a spin-echo sequence
(Figs. 1, 2, 3). The degree of signal attenuation in DWI
depends both on the magnitude of diffusion (also referred
to as intravoxel “incoherent” motion [19–21]) and the
amount of diffusion weighting. It should be realized that
only intravoxel “incoherent” motion leads to signal
decrease, whereas intravoxel “coherent” motion, irrespec-
tive of its magnitude, does not affect signal, as will be
explained in a later section. The amount of diffusion
weighting is determined by the so-called b-value (b) and is
calculated as follows:
b ¼ γ2G2δ
2 Δ   δ=3 ðÞ ;
where δ is the duration of one MPG, Δ is the interval
between the leading edges of the MPGs, Gis the strength of
the MPG (Fig. 1), and γ is the gyromagnetic ratio (the ratio
of the magnetic moment to the angular momentum of a
particle, 42.58 MHz/T for hydrogen) [7, 18].
In biological tissue, diffusion is expressed and quantified
by means of an effective or apparent diffusion coefficient
(ADC). If two or more images with different b-values are
acquired, the ADC of a selected region-of-interest (ROI) can
be calculated as follows:
ADC ¼ 1=b1   b0 ðÞ ln Sb 1 ½ 

Sb 0 ½ 

;
where b1 and b0 represent two different b-values, S[b1] the
signal intensity of the selected ROI on the slice level
acquired with b-value b1,a n dS[b0] the signal intensity of
the same ROI on the same slice level acquired with b-value
b0. A pixel by pixel map (so-called ADC map), whose
intensity yields quantitative estimation of the regional ADC,
can be obtained by post-processing [22].
DWI has potential in the field of oncological imaging.
Malignant tumors may exhibit either restricted or increased
diffusion, depending on their micro-architecture. For
example, tumors with a high cellular density possess more
cellular membranes per volume unit, which impedes the
mobility of water molecules and restricts diffusion. Failure
of the Na
+/K
+ATPase pump during necrotic cell death
(similar to acute ischemic stroke) may also lead to restricted
diffusion. Restricted diffusion has been reported for most
malignant tumors [9, 10, 23]. On the other hand, loss of cell
membrane integrity in necrotic tumors and decrease in
tumor cellularity due to necrosis and/or apoptotic processes
may result in increased diffusion, unless the necrotic fluid
itself possesses high viscosity. In addition, intratumoral
edema and cystic tumor components also increase diffusion
because of increased water content [9, 10, 23].
For a more in-depth overview of the current status of
conventional (breathhold or respiratory triggered) DWI, we
refer the reader to the articles by Thoeny and De Keyzer [9],
and Koh and Collins [10].
Concept of DWIBS
When DWI was applied to the chest and abdominal region,
another important problem was encountered: respiratory
Fig. 1 The Stejskal-Tanner sequence [5]( RF radio frequency, GM
readout direction, GP phase encoding direction, GS section select
direction, MPG motion probing gradient, δ duration of one MPG, Δ
time interval between the leading edges of the MPGs, TE echo time)
1938motion. It was known that T2-weighted image contrast
could be maintained in T2-weighted imaging during free
breathing. Nevertheless, breathholding or respiratory
triggering was preferred to avoid image blurring. Similar
rules seem to apply to DWI, but with a different underlying
theory. Most people believed that diffusion-weighted
image contrast would largely be lost in DWI during free
breathing, because respiratory motion is tremendously
larger than diffusion. Thus, DWI during free breathing
seemed to be impossible and breathholding or respiratory
triggering was strongly recommended, mainly to avoid
signal loss rather than image blurring. Because of its
limited scanning time, only a limited number of slices with
relatively large slice thickness could be obtained in each
examination, similar to incremental computed tomography
(CT). As a result, the signal-to-noise ratio (SNR) is low and
lesion conspicuity may be diminished. Respiratory triggered
scanning improves SNR, but at the expense of an
approximately threefold increase in scanning time.
As described previously, Takahara et al. [16] developed
the concept of DWIBS and proved the feasibility of DWI
during free breathing. They also observed that SNR of
DWI during free breathing considerably surpassed that of
breathhold scanning [16]. These observations were in
contradiction with the general assumption at that time.
They extended the possibilities of DWI: scanning time is
no more limited (as in breathhold scanning) and image
acquisition time is no moreconfined to aparticular phase of
the breathing cycle (as in respiratory triggered scanning),
images with multiple b-values including high b-values
around 1,000 s/mm
2 can be acquired, thin slices can be
obtained, and multiple signal averaging is possible. Further-
more, these advances enable volumetric [three-dimensional
(3D)] image processing, including maximum intensity
projections (MIPs), volume rendering, and multiplanar
reformatting (MPR) in any plane (Figs. 4 and 5).
Reason for the feasibility of free breathing in DWI
Sensitivity of DWI to microscopic diffusion (in the order of
several micrometers) is maintained even during free
breathing. To understand the feasibility of free breathing
in DWIBS, two types of motion should be distinguished:
intravoxel “incoherent” motion and intravoxel “coherent”
motion. Intravoxel “incoherent” motion refers to the
Fig. 2 Three stationary water molecules (A, B, C) in one voxel.
Phase shifts induced by the first motion probing gradient (MPG) are
nullified by the second MPG. Because of the maintained phase
coherence among the three water molecules, the MRI signal is not
attenuated (RF radio frequency)
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1939incoherent motion of water molecules within a voxel (i.e.,
diffusion) [19–21]. Intravoxel “coherent” motion refers to
the coherent motion of water molecules within a voxel.
Since the two MPGs in a diffusion-weighted sequence
(Fig. 1) are applied within a very small time interval (in the
order of 50 ms), additional respiratory motion can indeed
be regarded as coherent motion. The two MPGs only lead
to signal decrease in case of intravoxel “incoherent” motion
(i.e. diffusion), whereas signal is not affected by intravoxel
“coherent” motion caused by additional respiratory motion
(Movie clip 1). In other words, because DWIBS employs
single-shot EPI, the acquired phase shift due to respiratory
motion is equal in each phase-encoding step and, therefore,
does not affect image formation (Fig. 6)[ 7]. Thus, DWI
can be regarded as equal to T2-weighted imaging with
respect to respiratory motion. In other words, diffusion-
weighted image contrast is maintained during free breath-
ing, while breathholding or respiratory triggering reduces
image blurring. However, the SNR in DWI is significantly
less than in T2-weighted imaging. Therefore, instead of
aiming to reduce image blurring, it can be more
advantageous to improve the SNR in DWI by means of
free breathing scanning, which allows thin slice acquisitions
and multiple-slice excitations for volumetric imaging.
Practical implementation of DWIBS
Suggested sequences for DWIBS at 1.5 T are listed in
Table 1. It is currently recommended to obtain axial slices
in DWIBS, to minimize image distortion. Because DWIBS
allows obtaining thin axial slices (up to 4 mm), high quality
reformatted images can subsequently be created in any
plane. DWIBS is combined with either a short inversion
time inversion recovery (STIR) pre-pulse or a frequency-
selective [chemical shift selective (CHESS)] pre-pulse for
fat suppression. STIR theoretically gives superior global fat
suppression over an extended field of view, compared with
CHESS, because of its insensitivity to magnetic field
inhomogeneities [24]. Therefore, STIR can be used
everywhere in the body. In addition, STIR may be useful
in suppressing bowel signal, which may have a short T1
value, similar to that of fat. However, one of the main
disadvantages of STIR, compared with CHESS, is
decreased SNR because of partial loss of proton signal
during the inversion time [24]. Since abdominal organs
usually do not suffer significantly from magnetic field
inhomogeneities, CHESS can be used in this area, both to
increase SNR and to reduce image acquisition time.
Continuous whole-body imaging, however, usually re-
Fig. 3 Three water molecules (P, Q, R) in one voxel, undergoing
diffusion. Phase shifts induced by the first motion probing gradient
(MPG) are not nullified by the second MPG. Because of the
resulting phase dispersion among the three water molecules, the
MRI signal is attenuated (RF radio frequency)
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1940quires the use of STIR because of the presence of magnetic
field inhomogeneities in the neck, shoulder, lungs, and
lower extremities. On the other hand, it is possible to
optimize a whole-body examination by imaging each
station with the most appropriate fat suppression technique
(either STIR or CHESS). The b-value determines the
degree of background body signal suppression; b-values in
the range of 800–1,000 s/mm
2 generally result in good
background body signal suppression for tumor detection. It
should be realized that the use of a certain b-value
combined with STIR is more effective in background body
signal suppression than a combination of the same b-value
with CHESS. For homogeneous organs like the liver and
pancreas, background body signal suppression is of less
importance, and a b-value of 500 s/mm
2 is sufficient for
tumor detection in the majority of cases, while reducing
image acquisition time. On the other hand, for tumor
detection in organs with an already (normal) high signal
intensity in DWIBS, such as the prostate, b-values in the
order of 1,500–2,000 s/mm
2 can be applied. For signal
reception in DWIBS, either a built-in body coil or a surface
coil can be used. Advantages of a built-in body coil are
patient comfort and large coverage. However, although it
has been reported that image quality is clear enough for the
detection of lesions [25], the contrast-to-noise ratio (CNR)
is inferior to that of a surface coil. One approach to obtain
whole-body images using a surface coil is the use of a so-
called whole-body surface coil design. A whole-body
surface coil design combines a large number of seamlessly
integrated coil elements and independent radiofrequency
channels, which offers large anatomical coverage (in the
order of 200 cm) and allows image acquisition without any
time loss due to patient or coil repositioning. However, is it
also possible to perform a time-efficient whole-body
examination using only one surface coil with limited
coverage. In order to perform such an examination, an
additional table platform should be mounted on top of the
original patient table. Furthermore, spacers should be
placed between both tables to create space to move the
lower part of the surface coil from one station to the next.
As a result, the patient can remain in the same position,
repositioning of the surface coil to image the next station
requires only little additional time (<1 min per station), and
3D alignment among the imaged stations is maintained.
After completion of the examination, separately imaged
stations can be merged with sophisticated software,
creating the whole-body image (Fig. 7). Image acquisition
time for DWIBS is typically in the order of 5–7 min per 25-
cm coverage, when using STIR and a b-value of 1,000 s/
mm
2. Inverting the gray scale of DWIBS images makes
them resemble PET-like images (Figs. 4, 5). DWIBS can be
performed on state-of-the-art MRI systems supplied by all
major vendors, including GE Healthcare, Hitachi Medical
Systems, Philips Medical Systems, Siemens Medical
Solutions, and Toshiba Medical Solutions.
Potential applications of DWIBS in oncology
Staging
Primary tumors and distant metastases exhibiting restricted
diffusion can be identified with DWIBS. DWIBS may
especially be useful to detect relatively small lesions
because of its high CNR. It should be noted, however, that
evaluation of areas close to the heart and the diaphragm
may be hampered in DWIBS because of signal loss and
artifacts due to incoherent tissue motion. Nevertheless,
overall, DWIBS may be a very useful adjunct to anatomical
Fig. 4 Coronal maximum intensity projection DWIBS image
(inverted black-and-white gray scale) of a healthy 60-year-old
male volunteer. Normal high signal intensity (black on this image)
can be seen in the brain, spinal cord, nerves of the brachial plexus,
prostate, testis, penis, spleen, and cervical, axillary, pelvic, and
inguinal lymph nodes
1941MRI or CT, where small lesions may be obscured or
overlooked because of the large amount of image data, and
lesions in normal-sized organs may be missed (Fig. 8).
Accurate assessment of nodal status has important
therapeutic and prognostic significance in patients with
newly diagnosed cancers. Current cross-sectional imaging
modalities rely on insensitive size and morphologic criteria
and, thus, lack the desired accuracy for characterizing
lymph nodes [26]. DWIBS may be a valuable tool for the
identification and characterization of lymph nodes; normal
lymph nodes have a relatively restricted diffusion because
of their high cellular density and are well visualized with
Table 1 Suggested sequences for DWIBS at 1.5 T (++ very good, + good, +/− moderate, − poor, −− very poor; FOV field of view, RFOV
rectangular FOV, NA not applicable, TE echo time, TI inversion time, TR repetition time)
Name DWIBS-STIR DWIBS-CHESS
Main characteristics Most suitable for organs and body regions
suffering from large magnetic field
inhomogeneities
Most suitable for organs and body regions
without significant magnetic field
inhomogeneities
Useful in suppressing bowel signal Relatively higher SNR than DWIBS-STIR
Relatively lower SNR than DWIBS-CHESS Relatively less time-consuming than DWIBS-STIR
Relatively more time-consuming than DWIBS-CHESS
Suitability
Neck and shoulder ++ −
Chest ++ +
Abdomen and pelvis
Liver, pancreas, spleen + ++
Colon ++ +
Kidneys ++ +
Uterus, bladder + ++
Prostate + +
Extremities ++ +
Imaging parameters
Fat suppression STIR CHESS
b-value (s/mm
2) 1,000
a, b 1,000
a, b
Direction of MPGs Phase, frequency, and slice Phase, frequency, and slice
TR (ms) 10,205 7,800
TE (ms) 70 70
TI (ms) 180 NA
Parallel imaging factor 2 2
Halfscan factor 0.6 0.6
EPI factor 47 47
Slice orientation Axial Axial
No. of slices 60 60
Slice thickness/gap (mm) 4/0 4/0
FOV (mm) 400 400
RFOV (%) 70 70
Matrix 160 160
Scan percentage 70% 70%
Actual voxel size (mm
3) 2.5×3.6×4.0 2.5×3.6×4.0
Calculated voxel size (mm
3) 1.6×1.6×4.0 1.6×1.6×4.0
No. of signals averaged 10 6
Scan time 7 min 8 s 3 min 2 s
aFor imaging of the upper abdomen (including liver, spleen, and pancreas), a b-value of 500 s/mm
2 can be applied, if necessary combined
with respiratory triggered scanning
bFor tumor detection in the prostate, b-values in the order of 1,500–2,000 s/mm
2 can be applied
1942DWIBS, while surrounding fat tissue is suppressed
(Figs. 4, 5). Metastatic lymph nodes may have increased
cellular density or necrotic areas, which further restricts or
increases diffusion, respectively. However, it is still
unknown whether it is possible to differentiate healthy
lymph nodes or benign lymphadenopathy from malignant
lymph nodes using DWIBS with calculation of ADCs.
Nevertheless, DWIBS is an outstanding tool to identify
lymph nodes, irrespective of their histological composi-
tion. DWIBS, for example, may be complimentary to
nanoparticle-enhanced MRI, which has proven to be very
useful for the characterization of lymph nodes [27] but may
have difficulties in tracing them.
Monitoring response to therapy
Another potential application of DWIBS is in the
assessment of radiation and/or chemotherapy efficacy.
Currently, CTand anatomical MRI are the most commonly
used means for the follow-up of cancer patients. Serial
measurements of tumor dimensions are made, and criteria,
such as the World Health Organization (WHO) or
Response Evaluation Criteria in Solid Tumors (RECIST)
criteria are applied to assess therapeutic efficacy [28].
DWIBS can similarly be applied and its ability to obtain
(automated) total volume measurements may especially be
useful (Fig. 9). In the near future, it is expected that the
further development of multichannel coils and accelerated
parallel imaging will allow acquisition of true isotropic
high-resolution volume data sets.
A disadvantage of the current approach of obtaining
repetitive tumor size measurements on CTor MRI is that it
cannot be used to give an early assessment of the
effectiveness of radiation and/or chemotherapy. Early
identification of patients who are likely to show a poor
response to a certain treatment can be of great advantage: it
provides the opportunity to adjust individual treatment
regimes more rapidly, and sparing patients unnecessary
morbidity, expense and delay in initiation of effective
treatment. PET is a promising functional imaging modality
for the early assessment of response to therapy for various
tumors [29], but DWIBS, which is less expensive and does
not require any patient preparation, may also be of value.
Similar to PET, DWIBS is able to detect functional changes
in areas involved with tumor before structural changes
become visible (Fig. 10). In addition, the recently
introduced functional diffusion map (fDM) allows calcula-
tion and visualization of tumor ADC changes during
treatment and takes into account spatial heterogeneity of
tumor response; it has proved to be useful to predict
treatment response in brain tumor patients [30–32] and its
feasibility for evaluating treatment response of metastatic
bone disease from prostate cancer has recently been
presented [33]. Extracranial application of fDM analysis
in a DWIBS examination would be very attractive, but is
technologically challenging and requires further investiga-
tion. The accuracy and reproducibility of ADC mapping and
measurements in DWIBS, which are the primary requisites
for fDM analysis, should first be investigated.
Detection of tumor persistence or recurrence
Differentiating persistent or recurrent tumor tissue from
nontumoral posttherapeutic change is of great importance
for correct patient management, but is often difficult with
CT or anatomical MRI. Functional imaging techniques,
such as PET [34] may allow better differentiation. The less
expensive DWIBS may also be of value. It can be
hypothesized that persistent or recurrent tumor tissue will
Fig. 5 Coronal maximum intensity projection DWIBS image
(inverted black-and-white gray scale) of a healthy 53-year-old
female volunteer. Normal high signal intensity (black on this image)
can be seen in the brain, spinal cord, nerves of the brachial and
lumbosacral plexus, vertebral bone marrow, endometrium, spleen,
and cervical, axillary, pelvic, and inguinal lymph nodes
1943show a more restricted diffusion than treatment-related
changes,mainlybecauseofhighercellulardensity.However,
whether or not it is possible to differentiate persistent or
recurrent tumor tissue from nontumoral posttherapeutic
change using DWIBS still has to be determined.
Initial results of DWIBS in oncology
The few clinical studies on DWIBS [i.e., DWI using high
b-value (1,000 s/mm
2), the application of a fat suppression
pre-pulse, image acquisition during free breathing, and
multiple signal averaging] investigated only a small
number of patients, and their results have to be considered
as preliminary.
Ichikawa et al. [35] evaluated the usefulness of DWIBS
in the detection of colorectal adenocarcinoma. Thirty-three
consecutive patients with 33 endoscopic colonoscopically
proven colorectal cancers and another 15 controls with a
negative endoscopic colonoscopy were included. Visual
assessment of the DWIBS images resulted in high sensi-
tivity (91%, 20/22) and specificity (100%, 15/15). How-
ever, because no benign pathologies were included, the
specificity of DWIBS might have been overestimated [35].
Ichikawa et al. [36] also investigated the value of
DWIBS in the detection of pancreatic adenocarcinoma.
Twenty-six patients with pathologically proven pancreatic
adenocarcinoma and another 23 controls with either
chronic pancreatitis (n=20) or intraductal papillary muci-
nous tumors (n=3), without any evidence of pancreatic
adenocarcinoma during a minimum of 12 months of
clinicoradiological follow-up, underwent DWIBS. Visual
assessmentoftheDWIBSimagesresultedinhighsensitivity
(96.2%, 75/78) and specificity (98.6%, 68/69).
Tsushima et al. [37] investigated the value of DWIBS,
T2-weighted MRI, and DWIBS/T2-weighted MRI fusion
as a screening tool for the detection of abdominal
malignancies. Thirty-seven patients with a malignant
tumor (five renal cell carcinomas, four advanced gastric
carcinomas, four metastatic liver tumors, three pancreatic
carcinomas, two hepatocellular carcinomas, two cholan-
giocarcinomas, one bone lesion of lymphoma, one trans-
verse colon carcinoma, five rectal carcinomas, three
ovarian carcinomas, two prostate carcinomas, two meta-
static bone tumors, one peritoneal dissemination, one
recurrent colon carcinoma, and one ascending colon
carcinoma) and 73 patients without a malignant tumor
were retrospectively analyzed. Malignant tumors had
Fig. 6 Three stationary water molecules (X, Y, Z) in one voxel,
undergoing respiratory motion. Respiratory motion induces a linear
phase shift but does not cause phase dispersion. Because of the
maintained phase coherence among the three water molecules, MRI
signal is preserved (MPG motion probing gradient, RF radio
frequency)
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1944Fig. 7 Separately imaged
stations can be merged with
sophisticated software, creating
the whole-body image
1945Fig. 9 Volume measurement of a primary hepatic diffuse large B-
cell lymphoma in a 10-year-old girl using DWIBS. a Axial
respiratory-gated T2-weighted image shows a bulky mass occupying
most of the right lobe of the liver (asterisk). b Axial DWIBS image
(inverted black-and-white gray scale) at the same level clearly
visualizes the tumor with excellent contrast between the tumor and
surrounding tissue (asterisk). c Volume-rendered image using thin
slice (4 mm, no gap) DWIBS dataset shows the three-dimensional
shape of the tumor (colored red) and allows for tumor volume
measurement
Fig. 8 A 41-year-old man with distal esophageal cancer shown by
DWIBS but inconspicuous on T2-weighted MRI. a Axial T2-
weighted image shows a small high signal intensity lesion in
segment 7 of the liver (arrow), consistent with a cyst. No other
conspicuous lesions can be identified. b Axial DWIBS image
(inverted black-and-white gray scale) at the same level shows
abnormal signal intensity in the lower part of the esophagus (arrow),
consistent with esophageal carcinoma
1946pathologically been verified and the absence of a malig-
nancy in the controls was confirmed by clinical and
radiological (conventional MRI and contrast-enhanced CT)
findings. The areas under the receiver-operating character-
istic curves for the visual detection of malignant lesions of
DWIBS/T2-weighted MRI fusion (0.904) was significantly
higher than those of DWIBS (0.720, P<0.01) and T2-
weighted MRI (0.822, P<0.05). Both sensitivity and
specificity were higher in DWIBS/T2-weighted MRI
fusion (89.5% and 81.9%, respectively) compared with
those of DWIBS (72.4% and 59.0%; P<0.01 and P<0.001,
respectively), and the specificity of DWIBS/T2-weighted
MRI fusion (81.9%) was significantly higher than that of
T2-weighted MRI (68.8%, P<0.01). Limitations of this
study are its retrospective design, the presence of selection
bias, the use of an imperfect reference standard, and the
heterogeneity of the patient population [37].
Komori et al. [38] compared the lesion detection rates of
DWIBS and
18F-fluoro-2-deoxyglucose (FDG)-PET/CT in
16 consecutive patients with a total of 27 malignant lesions
(15 lung cancers, five pulmonary metastases of parathyroid
cancer, three pulmonary metastases of lung cancer, three
colon cancers, and one breast cancer). The lesions were
confirmed to be malignant by means of biopsy, surgery, or
a minimum clinical follow-up of six months. In addition,
seven regions showing slight accumulation of FDG
(standardized uptake value <2.5) were selected as reference
organs, and their ADCs (in × 10
−3 mm
2/s) were measured
and compared with those of the malignant lesions. Twenty-
five (92.6%) of 27 malignant lesions were detected visually
with DWIBS, in contrast to 22 malignant lesions (81.5%)
with FDG-PET/CT. However, there was no significant
difference between the mean ADCs of the reference organs
(n=7, 1.54±0.24 SD) and the malignant lesions (n=25,
1.18±0.70 SD). Unfortunately, diagnostic performance of
DWIBS in terms of sensitivity and specificity was not
assessed in this study. Furthermore, the heterogeneity of
the patient population may have led to overlapping ADCs
inreferenceorgansandmalignantlesions.Anotherdrawback
of this study is that it was not clear whether the readers were
blinded to the reference standard and FDG-PET/CT when
interpreting the DWIBS images [38].
Tamai et al. [39] performed DWIBS in 18 consecutive
females with surgically proven endometrial cancer and 12
Fig. 10 Comparison of pre- and post-chemotherapy FDG-PET and
DWIBS images in a 44-year-old man with diffuse large B-cell
lymphoma. a Coronal maximum intensity projection FDG-PET and
b coronal maximum intensity projection DWIBS images before
initiation of chemotherapy. Both images show cervical, bilateral
supra/infraclavicular, mediastinal, left axillary, para-aortic lymph
node, and splenic involvement (arrows), and cardiac involvement
(dashed arrow). c FDG-PET and d DWIBS images at the end of
treatment show resolvement of all pre-existing lesions. a, b A
limitation of DWIBS is that discrimination between normal and
metastatic lymph nodes is still based on size criteria; the FDG-PET
positive left cervical lymph node (arrowhead 1) cannot conclu-
sively be identified as malignant on DWIBS (arrowhead 1).
DWIBS also shows prominent bilateral inguinal lymph nodes
(encircled) which are normal according to FDG-PET. On the other
hand, thanks to its higher spatial resolution, DWIBS visualizes two
separate cardiac lesions (dashed arrow), whereas FDG-PET shows
only one large cardiac lesion (dashed arrow). DWIBS also allows
better evaluation of the urinary tract than FDG-PET, where potential
lesions can be obscured because of FDG accumulation (arrowheads
2). c Note the physiological FDG uptake in the large intestine
(arrow), which should not be confused with persistent malignant
lymphoma
1947cervical cancer patients with pathologically confirmed
normal endometrium. All endometrial cancers and the
normal endometria appeared hyperintense on DWIBS
images. The mean ADC (in × 10
−3 mm
2/s) of endometrial
cancer (0.88±0.16 SD) was significantly lower (P<0.01)
than that of normal endometrium (1.53±0.10 SD), without
any overlap between them. The mean ADC for each
histologic grade was 0.93±0.16 SD (grade I), 0.92±0.13
SD (grade 2), and 0.73±0.09 SD (grade 3). The ADC of
grade 3 tumors was significantly lower than that of grade 1
tumors (P<0.05). This study proved DWIBS to be feasible
in demonstrating endometrial cancer and suggests that
ADC measurement has a potential ability to differentiate
between normal and cancerous tissue in the endometrium.
Estimation of histologic grade based on ADCs seems
difficult because of considerable overlap. A limitation of
this study is that no benign endometrial pathologies were
included. Therefore, it is still unclear whether it is possible
to differentiate malignant from non-malignant endometrial
lesions using ADC measurements in DWIBS. ADCs of the
normal endometrium may vary according to menstrual
cycle in premenopausal women, but menstrual phase of the
patients was not taken into consideration in analyzing the
ADCs of the normal endometrium in the control group.
Another drawback of this study was the fact that readers
were not completely blinded when analyzing the images of
the control group [39].
Tamai et al. [40] also performed DWIBS in 43 surgically
treated patients with 58 myometrial tumors, including
seven uterine sarcomas (five leiomyosarcomas and two
endometrial stromal sarcomas) and 51 benign leiomyomas
(43 ordinary leiomyomas, two cellular leiomyomas and six
degenerated leiomyomas), in addition to conventional non-
enhanced and postcontrast MRI sequences. Both uterine
sarcomas and cellular leiomyomas exhibited high signal
intensity onDWIBS images, whereas ordinary leiomyomas
and most degenerated leiomyomas showed low signal
intensity. The mean ADC (in × 10
−3 mm
2/s) of sarcomas
(1.17±0.15 SD) was lower than those of the normal
myometrium (1.62±0.11 SD) and degenerated leiomyomas
(1.70±0.11 SD) without any overlap; however, they
overlapped with those of ordinary leiomyomas and cellular
leiomyomas. This study suggests that, in addition to
morphological features, DWIBS may be able to distinguish
uterine sarcomas from benign leiomyomas, although ADC
measurement may have a limited role due to a large overlap
between sarcomas and benign leiomyomas. A disadvan-
tage of this study is the nonconsecutive enrollment of
patients. Furthermore, menstrual phase of the patients was
not taken into account in the assessment of the ADC of the
normal myometrium [40].
Ballon et al. [17] investigated the feasibility of
monitoring response to therapy using DWIBS. Examples
presented in their study include the evaluation of therapeutic
response in bone marrow during cytotoxic therapy for
leukemiaandmetastaticprostatecancer,andduringcytokine
administration for marrow mobilization prior to stem cell
harvest [17].
Drawbacks and limitations of DWIBS
General
Although DWIBS offers many potential applications in
oncological imaging, it may sufferfrom several drawbacks.
First, DWIBS does not exclusively visualize malignant
tumors. Benign pathologies with restricted diffusion, such
as abscesses, will also exhibit high signal on DWIBS
source images (Fig. 11)[ 41]. Furthermore, DWIBS not
only visualizes pathological areas of restricted diffusion,
but also several normal structures; brain, salivary glands,
tonsils, spleen, gallbladder, small intestine/small intestinal
contents, colon, adrenal glands, prostate, testes, penis,
endometrium, ovaries, spinal cord, peripheral nerves,
lymph nodes, and bone marrow may all exhibit high signal
intensity on DWIBS source images (Figs. 4, 5, 10). High
signal intensities within these organs do not necessarily
indicate pathologic states, whereas true lesions within these
organs may be obscured. Visibility of the spleen is highly
variable and probably dependent on its iron content (and
consequent signal loss). T2 shine-through and insuffi-
ciently suppressed fat signal may also hinder image
interpretation. Although at the expense of prolonged
acquisition time, T2 shine-through effects can be removed
by performing ADC mapping, provided that ADC mapping
is accurate and feasible in DWIBS. Another limitation of
DWIBS is its suppression of background body signals, as a
result of which sufficient anatomical information is
lacking. Standard T1- and T2-weighted sequences there-
fore remain indispensable to act as an anatomical reference
frame for the DWIBS images, in order to exactly localize
lesions. DWIBS and anatomical (whole-body) MRI can be
viewed side-by side, or fused with commercially available
software (Fig. 12). An additional advantage of DWIBS/
anatomical MRI fusion may be increased sensitivity and
specificity [37]. Finally, although DWIBS images can be
post-processed to create MIPs and PET-like images, which
are very attractive for demonstration purposes (Figs. 4, 5,
10), source images should always be consulted, because
subtle lesions may be missed or obscured in projected
images.
ADC measurements in DWIBS
Signal intensity is directly related to the degree of diffusion
and the ADC is the quantitative measure of diffusion in
DWI. Both signal intensity and ADCs are mainstays in the
identification and characterization of lesions in DWI.
However, because of the allowance of respiratory motion
in DWIBS, slice levels of images obtained with different b-
1948values may not be identical. In addition, because DWIBS
employs multiple slice excitations, slices levels of images
obtained with the same b-value may be different.
Consequently, ADC measurements of moving organs in
DWIBS may be less accurate, less reproducible, and
different from conventional (breathhold or respiratory
triggered) DWI. In other words, DWIBS images of moving
organs are possibly more suitable for visual nonquantita-
tive evaluation than quantitative analysis. In their phantom
study, Muro et al. [42] reported that ADCs of slowly
moving phantoms, simulating respiratory motion, were no
more than 10% different from ADCs of static phantoms, if
the ROIs were placed (and remained) within the homoge-
neous phantom. However, if the ROIs covered the edge of
the phantom, ADCs were markedly different [42]. Thus,
the results of this study indicate that ADC measurements of
homogeneous tissue appear to be accurate, whereas ADC
measurements of heterogeneous tissue or small lesions
(e.g., pulmonary nodules or small liver lesions) may be
unreliable in DWIBS. Nasu et al. [43] compared ADCs of
hepatic malignant tumors in both respiratory triggered
DWI and DWIBS. Thirty patients with liver metastasis or
hepatocellular carcinoma in the right hepatic lobe were
examined. The mean measured ADC in respiratory
triggered DWI was 1.36 (± 0.33 SD), whereas the mean
measured ADC in DWIBS was 1.47 (± 0.61 SD). The
statistical difference between both mean ADCs was not
clear (P=0.050). The individual ADCs in DWIBS were
more scattered than those in respiratory triggered DWI
and there was no regular pattern in individual ADC
differences [43]. It should be noted, however, that the
comparison between respiratory triggered DWI and
DWIBS was (clinically) not fair, since roughly estimated
scanning time of respiratory triggered DWI was approxi-
mately 1.3- to 2-times longer [43]. In a similar
investigation with accurate time measurements, scanning
time in respiratory triggering was even nearly three-times
longer [44]. More in-vivo research is needed to determine
the accuracy and reproducibility of ADC measurements in
DWIBS.
Future considerations of DWIBS
More studies with large sample sizes are needed to
establish the value of DWIBS and to develop criteria for
differentiation between malignant and non-malignant
lesions. Future research is also warranted to optimize the
sequence for DWIBS. An important issue in DWIBS is the
optimization of background body signal suppression, while
maintaining high signal from areas with restricted diffu-
sion. Fat suppression is essential for lymph node and lesion
conspicuity in DWIBS. Takahara et al. [16] reported STIR
to be superior to CHESS for fat suppression in the neck/
upper chest region in DWIBS at 1.5 T. In addition, STIR
has the potential advantage to avoid false positive results
because of intestinal contents. However, there is no report
yet as to which technique is better for detecting intestinal
(e.g., colonic) tumors. Whether STIR or CHESS should be
preferred for DWIBS of the trunk at 1.5 T requires further
systematic investigation. Additionally, the utility of using
negative oral contrast agents should be investigated; the
use of a negative oral contrast agent may further aid in the
suppression of bowel signal [45], which is especially
important when evaluating (possible) gastrointestinal/intra-
Fig. 11 A 78-year-old man with metastatic lung cancer and two
benign lesions visualized with DWIBS. Coronal maximum intensity
projection DWIBS image shows an area with restricted diffusion in
the right lower lobe, consistent with lung cancer (arrow). In
addition, DWIBS image shows ipsilateral hilar lymph node
metastasis (arrowhead 1), retroperitoneal/adrenal metastasis (arrow-
head 2), and vertebral metastasis (arrowhead 3). DWIBS image also
shows restricted diffusion in a thoracic vertebra (arrowhead A). T1-
and T2-weighted images (not shown), however, indicate this
“lesion” to be a (benign) cavernous hemangioma, instead of a
vertebral metastasis. Furthermore, DWIBS image shows a well-
circumscribed area of restricted diffusion in the epigastric region
(arrowhead B); physical examination reveals a (benign) sebaceous
cyst to be responsible for this area of restricted diffusion
1949abdominal malignancies. DWIBS at 3.0 T potentially
offers higher SNR, since SNR increases linearly with
increasing field strength. Susceptibility artifacts, on the
other hand, increase exponentially with increasing field
strength, which will degrade DWIBS images [46]. A recent
feasibility study indeed reported DWIBS at 3.0 T to
provide a better lesion-to-bone tissue contrast, compared
with DWIBS at 1.5 T [47]. STIR proved to offerthe best fat
suppression in all body regions at 3.0 T [47]. However,
larger susceptibility-induced image distortions and signal
intensity losses, stronger blurring artifacts, and more
pronounced motion artifacts degraded the image quality
at 3.0 T [47]. Thus, further investigations concerning
DWIBS at 3.0 T should be undertaken. Image acquisition
Fig. 12 Fusion of a DWIBS image and a T2-weighted image in a
64-year-old man with ascending colon cancer. a Axial and b
coronally reformatted DWIBS images show abnormal signal in the
area of the ascending colon. c Axial and d coronal T2-weighted
images show a large mass of intermediate signal intensity in the
ascending colon, extending beyond the serosa. e Fused axial and f
coronal DWIBS/T2-weighted images, highlighting the lesion
Fig. 13 Comparison of DWIBS images obtained (1) during free
breathing, (2) with respiratory triggering, and (3) with TRON, in a
48-year-old male with hepatocellular carcinoma and hemochroma-
tosis. a Coronally reformatted DWIBS image obtained during free
breathing shows an area with restricted diffusion in segment IV of
the liver; biopsy proved this lesion to be a hepatocellular carcinoma
(HCC). Bile in the gallbladder (GB) also shows restricted diffusion.
Note significant blurring of the hepatocellular carcinoma and the
gallbladder, especially at their lower boundaries (arrowheads). b
Coronally reformatted DWIBS image obtained with respiratory
triggering results in reduced blurring of the hepatocellular carcino-
ma (HCC) and the gallbladder (GB), but introduces stepladder-like
artifacts due to gating error. Furthermore, image acquisition time is
approximately 2.5-times prolonged in comparison with a. c
Coronally reformatted DWIBS image obtained with TRON shows
slight gating error, but offers good delineation of the hepatocellular
carcinoma (HCC) and the gallbladder (GB). Image acquisition time
is only slightly (approximately 1.2-times) increased in comparison
with a
1950during free breathing is the hallmark and the driving force
behind the DWIBS sequence. A disadvantage of this free
breathing approach, however, is the possibility of image
blurring due to the periodic displacement of the diaphragm
(Fig. 13a), which may hamper adequate visualization of
small lesions near the diaphragm, such as in the liver.
Respiratory triggering may be used to reduce image
blurring (Fig. 13b), but increases image acquisition time.
The recently introduced tracking only navigator (TRON)
technique, however, adequately deals with both problems.
As the name implies, the navigator-echo in TRON is not
used to create a gating window (in other words, data
acquired during the entire breathing cycle can be used for
image formation), but is only used to track and correct for
displacements. Consequently, displaced organs and lesions
near the diaphragm can be visualized with less blurring and
with only minimal prolongation of scan time (Fig. 13c)
[44]. TRON is a very promising tool for DWIBS of
paradiaphragmatic organs and lesions, but its technical
performance (i.e. whether it routinely results in anatomically
faithful, reproducible images) still needs to be investigated.
Summary
Image acquisition during free breathing, multiple signal
averaging, and background body signal suppression by
means of a fat suppression pre-pulse and heavy diffusion
weighting, are the main features of DWIBS. DWIBS is a
diffusion-weighted sequence, but its (image) characteristics
are different from conventional (breathhold or respiratory
triggered) DWI. DWIBS highlights areas with restricted
diffusion, such as occurs in many malignant primary and
metastatic tumors, and provides an outstanding visualization
oflymphnodes.AlthoughtheexactvalueofDWIBSstillhas
to be established, it has potential use in tumor staging,
monitoringresponsetocancertherapy,andinthedetectionof
tumor persistence or recurrence.
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